ALLMedicine™ Barrett's Esophagus Center
Research & Reviews 1,834 results
https://doi.org/10.1097/MOG.0000000000000844
Current Opinion in Gastroenterology; Sawas T, Katzka DA
Jun 29th, 2022 - The incidence of esophageal adenocarcinoma (EAC) has increased significantly over the last several decades. The majority of EAC patients present without a prior history of Barrett's esophagus (BE). As a result, endoscopic surveillance has made a s...
https://doi.org/10.1016/j.soard.2022.05.012
Surgery for Obesity and Related Diseases : Official Journ... Uccelli M, Cesana GC et. al.
Jun 28th, 2022 - Gastroesophageal reflux disease (GERD), including erosive esophagitis, is highly prevalent in the obese population. Barrett's esophagus is the consequence of untreated GERD. Laparoscopic sleeve gastrectomy is one of the most frequently performed b...
https://doi.org/10.1002/ijc.34191
International Journal of Cancer; Hao Y, Karaoz U et. al.
Jun 26th, 2022 - The incidence of esophageal adenocarcinoma (EA) has drastically increased in the United States since 1970s for unclear reasons. We hypothesized that the widespread usage of antibiotics has increased the procarcinogenic potential of the orodigestiv...
https://doi.org/10.3390/cimb44030089
Current Issues in Molecular Biology; Lastraioli E, Iorio J et. al.
Jun 21st, 2022 - Preneoplastic lesions represent a useful target for early diagnosis and follow-up of gastrointestinal malignancies. hERG1 channel expression was tested by immunohistochemistry (IHC) in a cohort of colorectal adenoma samples belonging to Italian su...
https://doi.org/10.1016/j.gie.2022.06.017
Gastrointestinal Endoscopy; Frederiks CN, Overwater A et. al.
Jun 21st, 2022 - Focal cryoballoon ablation (FCBA) is currently investigated for the treatment of Barrett's esophagus (BE) related neoplasia in a European multicenter study (Euro-Coldplay study). After inclusion of 28/107 patients, the initial dose of 10 seconds (...
Guidelines 10 results
https://doi.org/10.1053/j.gastro.2019.09.051
Gastroenterology Sharma P, Shaheen NJ et. al.
Nov 16th, 2019 - The purpose of this best practice advice article is to describe the role of Barrett's endoscopic therapy (BET) in patients with Barrett's esophagus (BE) with dysplasia and/or early cancer and appropriate follow-up of these patients. The best pract...
https://doi.org/10.1016/j.gie.2019.05.012
Gastrointestinal Endoscopy; , Qumseya B et. al.
Aug 24th, 2019 - ASGE guideline on screening and surveillance of Barrett's esophagus.|2019| ,Qumseya B,Sultan S,Bain P,Jamil L,|diagnosis,pathology,diagnosis,pathology,diagnosis,pathology,
https://doi.org/10.1016/j.gie.2017.10.011
Gastrointestinal Endoscopy; , Wani S et. al.
Feb 6th, 2018 - Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplasia and intramucosal cancer.|2018| ,Wani S,Qumseya B,Sultan S,Agrawal D,|complications,diagnosis,pathology,surgery,etiology,surgery,
https://doi.org/10.1016/j.cgh.2016.10.023
Clinical Gastroenterology and Hepatology : the Official C... Acosta A, Streett S et. al.
Mar 1st, 2017 - The epidemic of obesity continues at alarming rates, with a high burden to our economy and society. The American Gastroenterological Association understands the importance of embracing obesity as a chronic, relapsing disease and supports a multidi...
https://doi.org/10.1053/j.gastro.2016.09.040
Gastroenterology Wani S, Rubenstein JH et. al.
Oct 6th, 2016 - The purpose of this clinical practice update expert review is to define the key principles in the diagnosis and management of low-grade dysplasia (LGD) in Barrett's esophagus patients. The best practices outlined in this review are based on releva...
Drugs 4 results see all →
Clinicaltrials.gov 245 results
https://clinicaltrials.gov/ct2/show/NCT05425771
Jun 21st, 2022 - Prospective, non-controlled, monocentric pilot study in patients with therapy-refractory reflux symptoms under proton pump inhibitor (PPI) therapy or intolerance of the necessary therapy or rapid recurrence of the symptoms with tapering therapy. T...
https://clinicaltrials.gov/ct2/show/NCT02197351
Jun 15th, 2022 - 1 BACKGROUND Precursor Lesions Gastric cancer is the fourth most common cancer and second leading cause of malignant death in the world. It often presents only with vague symptoms of dyspepsia and consequently is frequently diagnosed at advanced s...
https://clinicaltrials.gov/ct2/show/NCT04450628
Jun 13th, 2022 - Patients referred for antireflux surgery and/or hiatal hernia repair will be considered for enrollment. Standard preoperative evaluation will include esophagogastroduodenoscopy (EGD) to assess for intraluminal pathology including esophagitis, colu...
https://clinicaltrials.gov/ct2/show/NCT04457193
Jun 9th, 2022 - Barrett's esophagus (BE) is a precancerous lesion characterized by the replacement of the normal stratified squamous epithelium of the distal esophagus by intestinal metaplasia (IM). Non-dysplastic BE may progress to low-grade dysplasia (LGD), to ...
https://clinicaltrials.gov/ct2/show/NCT05412628
Jun 9th, 2022 - Esophageal cancer is one of the most common gastrointestinal malignant diseases worldwide with an estimated 456,000 incident cases annually. Esophageal cancer has a poor prognosis and high mortality rate. The 5-year survival rate is around 15%-25%...
News 187 results
https://www.medscape.com/viewarticle/976206
Jun 27th, 2022 - Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) each led to good and sustainable weight loss 10 years later, although reflux was more prevalent after SG, according to the Sleeve vs Bypass (SLEEVEPASS) randomized clinical trial. At 10 y...
https://www.medscape.com/viewarticle/974049
May 16th, 2022 - An alarming increase in both esophageal cancer (EC) and the primary precursor lesion for esophageal adenocarcinoma known as Barrett's esophagus (BE) has been observed among middle-aged adults over the past 5 years, and it's not due to better or mo...
https://www.medscape.com/viewarticle/973725
May 10th, 2022 - A rise in esophageal adenocarcinoma (EAC) cases and deaths showcases a need for noninvasive screening methods that can be performed by nonendoscopists, such as nurses or technicians, according to a presentation at the 2022 AGA Tech Summit that rev...
https://www.medscape.com/viewarticle/972484
May 3rd, 2022 - This transcript has been edited for clarity. Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia. Barrett's esophagus is something we all deal with in gastroenter...
https://www.medscape.com/viewarticle/971871
Apr 8th, 2022 - A swallowable, capsule-sponge device used to sample biomarkers offers a reliable, noninvasive alternative to endoscopy for diagnosing Barrett's esophagus, according to a new guideline from the American College of Gastroenterology. In addition, the...